 Connection
Jamie Studts to Neoplasms
This is a "connection" page, showing publications Jamie Studts has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.027 |
|
|
|
-
Glasgow RE, Brtnikova M, Dickinson LM, Carroll JK, Studts JL. Implementation strategies preferred by primary care clinicians to facilitate cancer prevention and control activities. J Behav Med. 2023 10; 46(5):821-836.
Score: 0.332
-
Eggly SS, Albrecht TL, Kelly K, Prigerson HG, Sheldon LK, Studts J. The role of the clinician in cancer clinical communication. J Health Commun. 2009; 14 Suppl 1:66-75.
Score: 0.124
-
Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, Edmondson D, Feliciano J, Hitsman B, Hudmon KS, Jaklitsch MT, Leone FT, Ling P, McCarthy DE, Ong MK, Park ER, Prochaska J, Sandoval AJ, Sheffer CE, Spencer S, Studts JL, Tanvetyanon T, Tindle HA, Tong E, Triplette M, Urbanic J, Videtic G, Warner D, Whitlock CW, McCullough B, Darlow S. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 03; 21(3):297-322.
Score: 0.082
-
Brtnikova M, Studts JL, Robertson E, Dickinson LM, Carroll JK, Krist AH, Cronin JT, Glasgow RE. Priorities for improvement across cancer and non-cancer related preventive services among rural and non-rural clinicians. BMC Prim Care. 2022 09 09; 23(1):231.
Score: 0.080
-
Burris JL, Borger TN, Shelton BJ, Darville AK, Studts JL, Valentino J, Blair C, Davis DB, Scales J. Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract. 2022 02; 18(2):e261-e270.
Score: 0.073
-
Waters EA, Taber JM, McQueen A, Housten AJ, Studts JL, Scherer LD. Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2389-2394.
Score: 0.070
-
Langford A, Studts JL, Byrne MM. Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors. Patient Educ Couns. 2021 02; 104(2):422-426.
Score: 0.069
-
Langford AT, Hawley ST, Stableford S, Studts JL, Byrne MM. Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives. J Cancer Educ. 2020 06; 35(3):454-461.
Score: 0.068
-
Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med. 1996 Sep-Oct; 25(5):527-36.
Score: 0.053
-
Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, Studts JL, Bridges JF, Close DR, Erwin DO, Jones RM, Kaiser K, Kash KM, Kelly KM, Craddock Lee SJ, Purnell JQ, Siminoff LA, Vadaparampil ST, Wang C. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3133-7.
Score: 0.033
-
Buist DS, Kanetsky PA, Studts JL, Li L, Terry MB, Trentham-Dietz A, Chang S. Recruiting and training leadership through professional societies: a report from the American Society of Preventive Oncology Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev. 2006 Jul; 15(7):1422-4.
Score: 0.026
-
Andrykowski MA, Lightner R, Studts JL, Munn RK. Hereditary cancer risk notification and testing: how interested is the general population? J Clin Oncol. 1997 May; 15(5):2139-48.
Score: 0.014
-
Cordova MJ, Studts JL, Hann DM, Jacobsen PB, Andrykowski MA. Symptom structure of PTSD following breast cancer. J Trauma Stress. 2000 Apr; 13(2):301-19.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|